Products

GMP Milrinone Injection 5mg/5ml 10mg /10ml Ampoule Phosphodiesterase Inhibitor

China GMP Milrinone Injection 5mg/5ml 10mg/10ml Ampoule Phosphodiesterase Inhibitor, Find details about China Milrinone, Phosphodiesterase Inhibitor from GMP Milrinone Injection 5mg/5ml 10mg/10ml Ampoule Phosphodiesterase Inhibitor

Model NO.
5mg/5ml 10mg/10ml
Pharmaceutical Technology
Chemical Synthesis
Molecular Formula
C12h9n3o
Molecular Weight
211.22
Character
Colorless Clear Liquid
Supplementary Materials
Sodium Chloride
Trademark
Without
Transport Package
5 Ampoules /Tray/Box
Specification
5mg/5ml 10mg/10ml
Origin
China
HS Code
3004909099
Model NO.
5mg/5ml 10mg/10ml
Pharmaceutical Technology
Chemical Synthesis
Molecular Formula
C12h9n3o
Molecular Weight
211.22
Character
Colorless Clear Liquid
Supplementary Materials
Sodium Chloride
Trademark
Without
Transport Package
5 Ampoules /Tray/Box
Specification
5mg/5ml 10mg/10ml
Origin
China
HS Code
3004909099
Milrinone injection

It  is used for the treatment of acute and chronic refractory congestive heart failure caused by various reasons, such as digitalis, diuretics, vasodilators, which are ineffective or ineffective.

Indication

It is suitable for the treatment of acute and chronic refractory congestive heart failure caused by various reasons, such as digitalis, diuretics and vasodilators.

Usage and dosage

Intravenous injection: load 25-75 μ g / kg, 5-10 minutes of slow intravenous injection, after every minute 0.25-1.0 μ g / kg maintenance.
The maximum daily dose shall not exceed 1.13mg/kg.

Oral: 2.5-7.5mg once, 4 times a day.

  Adverse reaction

It is less than amrinone. A few have headache, ventricular arrhythmia, weakness, thrombocytopenia and so on.
When overdose, there may be hypotension and tachycardia.
Long term oral administration is no longer used because of its side effects, which can lead to a long-term increase in mortality.

GMP Milrinone Injection 5mg/5ml 10mg/10ml Ampoule Phosphodiesterase Inhibitor
 

You Might Also Like